B12 does not affect the GLP-1 mechanism of action
Typically, roughly 25-40% of weight lost through caloric restriction comes from lean tissue rather than fat
Several large clinical studies, the majority of which are cardiovascular outcome trials, indicate that GLP-1 RA therapy is safe and tolerable for people living with T2DM and compromised renal function, and also suggest that GLP-1 RAs may have renoprotective properties
When using it in combination with other weight loss drugs, be sure to do so under the guidance and management of a doctor
Furthermore, a comprehensive review published in the Journal of Translational Medicine proposed a unifying model for ME/CFS and Long COVID, highlighting how viral infections (like SARS-CoV-2 or Epstein-Barr Virus) trigger a cascade of immune exhaustion, micro-clotting, and severe oxidative stress